Testing effectiveness (Phase 2)UnknownNCT05164393
What this trial is testing
Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
Who this might be right for
Actinic Keratoses
Coegin Pharma AB 60